"The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections.
Dalvance is intended to treat acute bacterial skin and skin structure infections (ABSSSI) cau"...
- Patient Information:
Details with Side Effects
Naftin® (naftifine) Gel, 1% is indicated for the topical treatment of tinea pedis, tinea cruris and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans* and Epidermophyton floccosum.*
*Efficacy for this organism in this organ system was studied in fewer than 10 infections.
DOSAGE AND ADMINISTRATION
A sufficient quantity of Naftin® (naftifine) Gel, 1% should be gently massaged into the affected and surrounding skin areas twice a day in the morning and evening. The hands should be washed after application. If no clinical improvement is seen after four weeks of treatment with Naftin® (naftifine) Gel, 1%, the patient should be re-evaluated.
Naftin® (naftifine hydrochloride) 1% Gel is supplied in collapsible tubes in the following sizes:
20g - NDC 0259-4770-20
40g - NDC 0259-4770-40
60g - NDC 0259-4770-60
Note: Store at room temperature.
Manufactured for: Merz Pharmaceuticals, Greensboro, NC 27410. Rev 4/04. FDA rev date: 9/26/2007
Last reviewed on RxList: 6/11/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Naftin Gel Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.